{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:44:44Z","timestamp":1793411084666,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2020-ZLLH-45"],"award-info":[{"award-number":["2020-ZLLH-45"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["No.2019-KF-01-02"],"award-info":[{"award-number":["No.2019-KF-01-02"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adenomatoid tumors (ATs) are benign tumors originating from the mesothelium. ATs of the ovary are rare, and can easily be confused with malignancy due to the histomorphological diversity. Thus, it is difficult in histopathological and differential diagnosis, especially during intraoperative frozen pathological diagnosis, which directly affects the resection scope of surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>In this study, we reported two patients (58 and 41\u00a0year old) with ovarian ATs. AT of patient 1 occurred in both ovaries at different time points and she had been diagnosed with Hashimoto's thyroiditis. AT of patient 2 occurred in right ovary. Intraoperative frozen pathological diagnosis was performed in both cases and laparoscopic salpingo-oophorectomy was undergone on the lesion side according to benign freezing diagnostic result. Ovarian ATs, the final diagnoses of the 2 cases were concluded after histological, extensive immunohistochemical (IHC), histochemical, and fluorescence in situ hybridization analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results show that ovarian ATs may not be related to BAP1 or CDKN2A\/p16 mutations. In addition, the case 1 suggests that ATs may be associated with immune dysregulation. When encountering such similar lessions, we recommend that a series of immunohistochemical, histochemical and molecular biological techniques should be used for diagnosis and differential diagnosis to avoid misdiagnosis. Improving understanding of the rare ovarian ATs which mimic malignancy is necessary to prevent overresection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-022-02138-6","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T11:09:16Z","timestamp":1672052956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adenomatoid tumors of ovary mimicking malignancy: report of 2 cases and literature review"],"prefix":"10.1186","volume":"22","author":[{"given":"Lili","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-7624","authenticated-orcid":false,"given":"Yanmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"issue":"5","key":"2138_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00428-011-1054-5","volume":"458","author":"DL Wachter","year":"2011","unstructured":"Wachter DL, W\u00fcnsch PH, Hartmann A, Agaimy A. Adenomatoid tumours of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specifific morphologic diversity. Virchows Arch. 2011;458(5):593\u2013602.","journal-title":"Virchows Arch"},{"issue":"9","key":"2138_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/modpathol.2009.90","volume":"22","author":"AR Sangoi","year":"2009","unstructured":"Sangoi AR, McKenney JK, Schwartz EJ, Rouse RV, Longacre TA. Adenomatoid tumours of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases. Mod Pathol. 2009;22(9):1228\u201335.","journal-title":"Mod Pathol"},{"key":"2138_CR3","unstructured":"Sakaguchi Y. \u00dcber das Adenomyom des Nebenhodens Ztschr. Path. 1916;p. 379\u201387."},{"issue":"1","key":"2138_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00004347-200201000-00007","volume":"21","author":"FF Nogales","year":"2002","unstructured":"Nogales FF, Isaac MA, Hardisson D, Bosincu L, Palacios J, Ordi J, et al. Adenomatoid tumours of the uterus: an analysis of 60 cases. Int J Gynecol Pathol. 2002;21(1):34\u201340.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"2138_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00004347-199110000-00009","volume":"10","author":"RH Young","year":"1991","unstructured":"Young RH, Silva EG, Scully RE. Ovarian and juxtaovarian adenomatoid tumors: a report of six cases. Int J Gynecol Pathol. 1991;10(4):364\u201371.","journal-title":"Int J Gynecol Pathol"},{"key":"2138_CR6","doi-asserted-by":"publisher","first-page":"151553","DOI":"10.1016\/j.anndiagpath.2020.151553","volume":"47","author":"B Ersan Erdem","year":"2020","unstructured":"Ersan Erdem B, Yaprak Bayrak B, Vural C, Muezzinoglu B. Non-random adenomatoid tumours of the female genital system: a comparative clinicopathologic analysis of 14 cases. Ann Diagn Pathol. 2020;47:151553.","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"2138_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/biores.2018.0023","volume":"7","author":"J Orlando","year":"2018","unstructured":"Orlando J, deRiese C, Blackwell E, Graham S, Phy J. Diagnosis and management of an adenomatoid uterine tumour: ultrasound, magnetic resonance imaging, surgical appearance, and pathology correlation. Biores Open Access. 2018;7(1):159\u201364.","journal-title":"Biores Open Access"},{"issue":"4","key":"2138_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1341-8076.2003.00102.x","volume":"29","author":"S Hanada","year":"2003","unstructured":"Hanada S, Okumura Y, Kaida K. Multicentric adenomatoid tumours involving uterus, ovary, and appendix. J Obstet Gynaecol Res. 2003;29(4):234\u20138.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"2138_CR9","first-page":"159","volume":"18","author":"T Hirakawa","year":"1988","unstructured":"Hirakawa T, Tsuneyoshi M, Enjoji M. Adenomatoid tumor of the ovary: an immunohistochemical and ultrastructural study. Jpn J Clin Oncol. 1988;18(2):159\u201366.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"2138_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jcu.20122","volume":"33","author":"MA Ghossain","year":"2005","unstructured":"Ghossain MA, Chucrallah A, Kanso H, Aoun NJ, Abboud J. Multilocular adenomatoid tumor of the ovary: ultrasonographic findings. J Clin Ultrasound. 2005;33(5):233\u20136.","journal-title":"J Clin Ultrasound"},{"issue":"1","key":"2138_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.pgp.0000215303.24653.fc","volume":"26","author":"V Phillips","year":"2007","unstructured":"Phillips V, McCluggage WG, Young RH. Oxyphilic adenomatoid tumor of the ovary: a case report with discussion of the differential diagnosis of ovarian tumors with vacuoles and related spaces. Int J Gynecol Pathol. 2007;26(1):16\u201320.","journal-title":"Int J Gynecol Pathol"},{"key":"2138_CR12","first-page":"3702682","volume":"2017","author":"M Shi","year":"2017","unstructured":"Shi M, Al-Delfi F, Al Shaarani M, Knowles K, Cotelingam J. Ovarian adenomatoid tumor coexisting with mature cystic teratoma: a rare case report. Case Rep Obstet Gynecol. 2017;2017:3702682.","journal-title":"Case Rep Obstet Gynecol"},{"issue":"2","key":"2138_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/1097-0142(195803\/04)11:2<337::AID-CNCR2820110218>3.0.CO;2-0","volume":"11","author":"JR Jackson","year":"1958","unstructured":"Jackson JR. The histogenesis of the adenomatoid tumor of the genital tract. Cancer. 1958;11(2):337\u201350.","journal-title":"Cancer"},{"issue":"3","key":"2138_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4065\/78.3.350","volume":"78","author":"PA Isotalo","year":"2003","unstructured":"Isotalo PA, Nascimento AG, Trastek VF, Wold LE, Cheville JC. Extragenital adenomatoid tumour of a mediastinal lymph node. Mayo Clin Proc. 2003;78(3):350\u20134.","journal-title":"Mayo Clin Proc"},{"key":"2138_CR15","first-page":"720","volume":"1","author":"P Masson","year":"1942","unstructured":"Masson P, Riopelle JL, Simard LC. Le m\u00e9soth\u00e9liome b\u00e9nin de la sphere g\u00e9nitale. Rev can biol. 1942;1:720\u201351.","journal-title":"Rev can biol"},{"issue":"3","key":"2138_CR16","first-page":"461","volume":"19","author":"N Evans","year":"1943","unstructured":"Evans N. Mesotheliomas of the uterine and tubal serosa and the tunica vaginalis testis: report of four cases. Am J Pathol. 1943;19(3):461\u201371.","journal-title":"Am J Pathol"},{"issue":"1","key":"2138_CR17","first-page":"63","volume":"21","author":"A Golden","year":"1945","unstructured":"Golden A, Ash JE. Adenomatoid tumors of the genital tract. Am J Pathol. 1945;21(1):63\u201379.","journal-title":"Am J Pathol"},{"issue":"7489","key":"2138_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature13109","volume":"506","author":"M Parker","year":"2014","unstructured":"Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y, et al. C11orf95-RELA fusions drive oncogenic NF-kB signaling in ependymoma. Nature. 2014;506(7489):451\u20135.","journal-title":"Nature"},{"issue":"7","key":"2138_CR19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/neuonc\/now025","volume":"18","author":"D Figarella-Branger","year":"2016","unstructured":"Figarella-Branger D, Lechapt-Zalcman E, Tabouret E, J\u00fcnger S, de Paula AM, Bouvier C, et al. Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling. Neuro Oncol. 2016;18(7):919\u201327.","journal-title":"Neuro Oncol"},{"issue":"4","key":"2138_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/modpathol.2017.153","volume":"31","author":"B Goode","year":"2018","unstructured":"Goode B, Joseph NM, Stevers M, Van Ziffle J, Onodera C, Talevich E, et al. Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. Mod Pathol. 2018;31(4):660\u201373.","journal-title":"Mod Pathol"},{"issue":"1","key":"2138_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","volume":"32","author":"M Stevers","year":"2019","unstructured":"Stevers M, Rabban JT, Garg K, Van Ziffle J, Onodera C, Grenert JP, et al. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Mod Pathol. 2019;32(1):88\u201399.","journal-title":"Mod Pathol"},{"issue":"2","key":"2138_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/modpathol.2016.188","volume":"30","author":"NM Joseph","year":"2017","unstructured":"Joseph NM, Chen YY, Nasr A, Yeh L, Talevich E, Onodera C, et al. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. Mod Pathol. 2017;30(2):246\u201354.","journal-title":"Mod Pathol"},{"issue":"8","key":"2138_CR23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","volume":"28","author":"M Cigognetti","year":"2015","unstructured":"Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, et al. BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol. 2015;28(8):1043\u201357.","journal-title":"Mod Pathol"},{"issue":"10","key":"2138_CR24","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","volume":"28","author":"J Andrici","year":"2015","unstructured":"Andrici J, Sheen A, Sioson L, Wardell K, Clarkson A, Watson N, et al. Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Mod Pathol. 2015;28(10):1360\u20138.","journal-title":"Mod Pathol"},{"issue":"4","key":"2138_CR25","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jtho.2016.12.019","volume":"12","author":"N Leblay","year":"2017","unstructured":"Leblay N, Lepretre F, Le Stang N, Gautier-Stein A, Villeneuve L, Isaac S, et al. BAP1 is altered by copy number loss, mutation, and\/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas. J Thorac Oncol. 2017;12(4):724\u201333.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2138_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/dc.23837","volume":"46","author":"I Cozzi","year":"2018","unstructured":"Cozzi I, Oprescu FA, Rullo E, Ascoli V. Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions. Diagn Cytopathol. 2018;46(1):9\u201314.","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"2138_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/PAS.0000000000000976","volume":"42","author":"R Pillappa","year":"2018","unstructured":"Pillappa R, Maleszewski JJ, Sukov WR, Bedroske PP, Greipp PT, Boland JM, et al. Loss of BAP1 expression in atypical mesothelial proliferations helps to predict malignant mesothelioma. Am J Surg Pathol. 2018;42(2):256\u201363.","journal-title":"Am J Surg Pathol"},{"key":"2138_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.humpath.2018.05.001","volume":"79","author":"HE Lee","year":"2018","unstructured":"Lee HE, Molina JR, Sukov WR, Roden AC, Yi ES. BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma. Hum Pathol. 2018;79:168\u201376.","journal-title":"Hum Pathol"},{"issue":"4","key":"2138_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/00004347-199210000-00007","volume":"11","author":"EG Livingston","year":"1992","unstructured":"Livingston EG, Guis MS, Pearl ML, Stern JL, Brescia RJ. Diffuse adenomatoid tumor of the uterus with a serosal papillary cystic component. Int J Gynecol Pathol. 1992;11(4):288\u201392.","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"2138_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00004347-200304000-00015","volume":"22","author":"CL Cheng","year":"2003","unstructured":"Cheng CL, Wee A. Diffuse uterine adenomatoid tumor in an immunosuppressed renal transplant recipient. Int J Gynecol Pathol. 2003;22(2):198\u2013201.","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"2138_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0301-2115(99)00290-0","volume":"92","author":"M Bulent Tiras","year":"2000","unstructured":"Bulent Tiras M, Noyan V, S\u00fcer O, Bali M, Edali N, Yildirim M. Adenomatoid tumor of the uterus in a patient with chronic renal failure. Eur J Obstet Gynecol Reprod Biol. 2000;92(2):205\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"2138_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/IGC.0b013e31819bc8f9","volume":"19","author":"MF Acikalin","year":"2009","unstructured":"Acikalin MF, Tanir HM, Ozalp S, Dundar E, Ciftci E, Ozalp E. Diffuse uterine adenomatoid tumor in a patient with chronic hepatitis C virus infection. Int J Gynecol Cancer. 2009;19(2):242\u20134.","journal-title":"Int J Gynecol Cancer"},{"key":"2138_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.gore.2016.05.003","volume":"17","author":"T Mizutani","year":"2016","unstructured":"Mizutani T, Yamamuro O, Kato N, Hayashi K, Chaya J, Goto N, et al. Renal transplantation-related risk factors for the development of uterine adenomatoid tumors. Gynecol Oncol Rep. 2016;17:96\u20138.","journal-title":"Gynecol Oncol Rep"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-02138-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T11:09:30Z","timestamp":1672052970000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-02138-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2138"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-02138-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the ethics committee of the Liaoning Cancer Hospital and Institute (Ethics Committee Approval Document: 20200815YG, 2020.9.19-2021.9.18).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from both patients for the publication of the 2 case reports and the accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"547"}}